What does CUSIP 640268108 represent in this 13F holders report?

CUSIP 640268108 is the security identifier for NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in Q2 2019?

327 institutional investors reported NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value for Q2 2019. Use the holders table for investor-level position and value details.

NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

CUSIP: 640268108

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 29,109,163
Total 13F shares: 165,918,824
Share change: +23,348,616
Total reported value: $5,899,886,319
Put/Call ratio: 208%
Reported price per share: $35.58
Number of holders: 327
Value change: +$833,932,879
Number of buys: 152
Number of sells: 157

Security key

640268108

Report period

Q2 2019

Institutions

327

Top holders

NKTR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2019 Previous quarter: Q1 2019 NEKTAR THERAPEUTICS SEC filings NEKTAR THERAPEUTICS company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 640268108

Newer quarter: Q3 2019 Previous quarter: Q1 2019

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

FMR LLC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2019

13F Lead comparable stake: 70% Showing first 8 of 50 holder rows. Open remaining rows

Rank 1 holder

FMR LLC

13F

Ownership: 70%
Position: $686.34M

13F

Rank 2 holder

PRIMECAP MANAGEMENT CO/CA/

13F

Ownership: 66%
Position: $650.36M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	70%	$686,344,000 20,426,894 shares	—	31 Mar 2019
PRIMECAP MANAGEMENT CO/CA/	13F Company 13F	66%	$650,356,000 19,355,822 shares	—	31 Mar 2019
VANGUARD GROUP INC	13F Company 13F	62%	$610,062,000 18,156,579 shares	—	31 Mar 2019
OppenheimerFunds, Inc.	13F Company 13F	59%	$581,377,000 17,302,891 shares	—	31 Mar 2019
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	45%	$435,507,000 12,961,558 shares	—	31 Mar 2019
BlackRock Finance, Inc.	13F Company 13F	43%	$420,516,000 12,515,343 shares	—	31 Mar 2019
STATE STREET CORP	13F Company 13F	24%	$238,523,000 7,098,904 shares	—	31 Mar 2019
JANUS HENDERSON GROUP PLC	13F Company 13F	8.5%	$82,752,000 2,462,860 shares	—	31 Mar 2019

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	8.2%	$80,433,000 2,398,081 shares	—	31 Mar 2019
JPMORGAN CHASE & CO	13F Company 13F	7.5%	$73,099,000 2,175,516 shares	—	31 Mar 2019
FIRST TRUST ADVISORS LP	13F Company 13F	7.4%	$72,212,000 2,149,180 shares	—	31 Mar 2019
BB BIOTECH AG	13F Company 13F	6.9%	$67,895,000 2,020,676 shares	—	31 Mar 2019
Invesco Ltd.	13F Company 13F	6.9%	$67,748,000 2,016,288 shares	—	31 Mar 2019
Camber Capital Management LP	13F Company 13F	6.9%	$67,200,000 2,000,000 shares	—	31 Mar 2019
NORGES BANK	13F Company 13F	6.7%	$65,138,000 1,938,621 shares	—	31 Mar 2019
NORTHERN TRUST CORP	13F Company 13F	6.3%	$61,739,000 1,837,456 shares	—	31 Mar 2019
Bank of New York Mellon Corp	13F Company 13F	5%	$48,526,000 1,444,210 shares	—	31 Mar 2019
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	4.8%	$46,921,000 1,396,464 shares	—	31 Mar 2019
BRIDGER MANAGEMENT, LLC	13F Company 13F	4.3%	$41,613,000 1,238,489 shares	—	31 Mar 2019
AQR CAPITAL MANAGEMENT LLC	13F Company 13F	4.2%	$40,987,000 1,230,092 shares	—	31 Mar 2019
D. E. Shaw & Co., Inc.	13F Company 13F	4.2%	$40,764,000 1,213,221 shares	—	31 Mar 2019
Artal Group S.A.	13F Company 13F	3.1%	$30,240,000 900,000 shares	—	31 Mar 2019
FRONTIER CAPITAL MANAGEMENT CO LLC	13F Company 13F	2.8%	$27,833,000 828,350 shares	—	31 Mar 2019
MORGAN STANLEY	13F Company 13F	2.8%	$27,710,000 824,659 shares	—	31 Mar 2019
GOLDMAN SACHS GROUP INC	13F Company 13F	2.7%	$26,613,000 792,043 shares	—	31 Mar 2019
First Light Asset Management, LLC	13F Company 13F	2.6%	$25,650,000 763,403 shares	—	31 Mar 2019
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F Company 13F	2.5%	$24,804,796 738,238 shares	—	31 Mar 2019
Rhenman & Partners Asset Management AB	13F Company 13F	2.5%	$24,677,000 734,445 shares	—	31 Mar 2019
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	2.5%	$24,298,000 723,146 shares	—	31 Mar 2019
Sumitomo Mitsui Trust Group, Inc.	13F Company 13F	2.3%	$22,928,000 682,377 shares	—	31 Mar 2019
RICE HALL JAMES & ASSOCIATES, LLC	13F Company 13F	2.3%	$22,524,000 670,359 shares	—	31 Mar 2019
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	2.2%	$21,753,000 647,578 shares	—	31 Mar 2019
TOBAM	13F Company 13F	2.2%	$21,522,000 640,547 shares	—	31 Mar 2019
Legal & General Group Plc	13F Company 13F	2.1%	$20,816,000 620,002 shares	—	31 Mar 2019
TIAA CREF INVESTMENT MANAGEMENT LLC	13F Company 13F	2%	$19,433,000 578,377 shares	—	31 Mar 2019
Swiss National Bank	13F Company 13F	2%	$19,404,000 577,500 shares	—	31 Mar 2019
TEACHERS ADVISORS, LLC	13F Company 13F	1.9%	$18,376,000 546,897 shares	—	31 Mar 2019
State of New Jersey Common Pension Fund D	13F Company 13F	1.9%	$18,144,000 540,000 shares	—	31 Mar 2019
DEUTSCHE BANK AG\	13F Company 13F	1.8%	$17,980,000 535,228 shares	—	31 Mar 2019
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	1.7%	$17,104,000 509,048 shares	—	31 Mar 2019
Cormorant Asset Management, LP	13F Company 13F	1.7%	$16,800,000 500,000 shares	—	31 Mar 2019
CREDIT SUISSE AG/	13F Company 13F	1.6%	$15,927,000 474,057 shares	—	31 Mar 2019
WELLS FARGO & COMPANY/MN	13F Company 13F	1.6%	$15,504,000 461,406 shares	—	31 Mar 2019
Bellevue Group AG	13F Company 13F	1.5%	$14,449,000 430,026 shares	—	31 Mar 2019
S.c.a. Candriam	13F Individual 13F	1.5%	$14,408,000 428,791 shares	—	31 Mar 2019
RHUMBLINE ADVISERS	13F Company 13F	1.3%	$12,884,000 383,451 shares	—	31 Mar 2019
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F Company 13F	1.3%	$12,486,000 371,594 shares	—	31 Mar 2019
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F Company 13F	1.2%	$11,961,000 355,992 shares	—	31 Mar 2019
Assured Investment Management LLC	13F Company 13F	1.1%	$10,434,000 310,528 shares	—	31 Mar 2019
AustralianSuper Pty Ltd	13F Company 13F	1.1%	$10,418,000 310,063 shares	—	31 Mar 2019

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

327

165,918,824

Rows loaded

328

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

340

Q2 2019 holders

327

Holder diff

-13

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q2 2019 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

Q2 2019 13F Holders as of 30 Jun 2019

Holder history for CUSIP 640268108

Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

FMR LLC

PRIMECAP MANAGEMENT CO/CA/

VANGUARD GROUP INC

Institutional holders as of Q2 2019

Compare Q2 2019 vs Q1 2019 Across Filers